A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology

David Scott Miller, John A. Blessing, Richard D. Drake, Robert Higgins, D. Scott McMeekin, Louis V. Puneky, Carolyn N. Krasner

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology'. Together they form a unique fingerprint.

Medicine & Life Sciences